Evidence map›Paper›PMID 32814585›Full record

ArticleLipids in health and disease2020

Association of CYP19A1 and CYP1A2 genetic polymorphisms with type 2 diabetes mellitus risk in the Chinese Han population.

Yafeng Yang, Ping Wang

Open access · goldAbstract read
In one paragraph

Article in Lipids in health and disease, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 19 citations in OpenAlex.

  1. Annals of medicine · 2025
    Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Coffee Consumption andJournal of personalized medicine · 2024
    Article
  7. Hypoglycemic Effects and Quality Marker Screening ofMolecules (Basel, Switzerland) · 2024
    Article
  8. Association between the aromatase (Archives of endocrinology and metabolism · 2024
    Article
  9. A Review: Cytochrome P450 in Alcoholic and Non-Alcoholic Fatty Liver Disease.Diabetes, metabolic syndrome and obesity : targets and therapy · 2024
    Review
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Yafeng YangDepartment of clinical nutrition, Xianyang Central Hospital, Xianyang, 712000, Shaanxi Province, China.
Ping WangDepartment of hemodialysis, Xianyang Central Hospital, Xianyang, 712000, Shaanxi Province, China. 1140726733@qq.com.ORCID http://orcid.org/0000-0002-6515-0734
Xian Yang Central Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundType 2 diabetes mellitus (T2DM), one of the global health issues, is a group of metabolic diseases and is affected by several genetic loci in the clinical phenotype. This study intended to ascertain associations between CYP19A1 and CYP1A2 gene polymorphisms with the T2DM risk in Chinese Han.

methodsSeven single nucleotide polymorphisms (SNPs) in total including five of CYP19A1 (rs4646, rs6493487, rs1062033, rs17601876 and rs3751599) and two of CYP1A2 (rs762551 and rs2470890) from 512 T2DM patients and 515 non-diabetic controls were genotyped in the platform of Agena MassARRAY. SPSS 18.0 was utilized for analyzing genotyping results. Logistic regression models were conducted for the risk assessment by the odds ratios (ORs) and 95% confidence intervals (CIs).

resultsThe results suggested a significant association between genotype GC of rs1062033 with a decreased T2DM risk (OR = 0.73, 95% CI = 0.55-0.96, P = 0.025) under the co-dominant (heterozygous) model. The results of stratification analysis with age and gender adjustment revealed that the effects of all selected SNPs in CYP19A1 and CYP1A2 on the T2DM susceptibility were dependent on age, body mass index (BMI) and disease progression (P <  0.05). The haplotype analysis was further conducted and the results indicated that C

conclusionThis population-based case-control study suggested that CYP19A1 and CYP1A2 variations might affect the susceptibility of T2DM. The findings provide a theoretical basis for searching the clinical therapeutic markers and attractive drug targets of T2DM.

Indexed as

Polymorphism, Single NucleotideAgedAromataseAsian PeopleCase-Control StudiesCytochrome P-450 CYP1A2Diabetes Mellitus, Type 2FemaleGenetic Predisposition to DiseaseHaplotypesHumansMaleMiddle AgedAromataseCYP19A1 protein, humanCYP1A2 protein, humanCytochrome P-450 CYP1A2CYP19A1CYP1A2Single nucleotide polymorphismType 2 diabetes mellitus

Identifiers

PMID32814585
PMCPMC7437009
OpenAlexW3057142253

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.